JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?=iM*WWj:W)s m/0=łY)R%cYcHO=RbE9T3vF;P唁33]CQU!!I}j\F)3qqPxdtҼjmV;bu^΢-3T5R eF\5Uq{֘Xv;*$:V|?.cr2H(Ż*RJ-- Ehb? 9>Ź4 ~{Λ4^(oIh[u$x#=j?AoYppoONpFsS]4DMiln8桫;"j'$);!]U )}ktxcK5U98rz+ZU/1IWw6W:W&I"1QS+YoBKe $ дW>q[#)]6\)W|FO :z 䕵{t4\ &cm&ѝOfI5 q:,=\~zW/ol-;U.vǧ] 4g$g 3Mu~;֨f0z+rӺV:F)($2s֊( uz]h PNcX2ikrkvꤖdvSAc;>E=)2ָ NM1\UBf:"Z0|C1uu@#}k;Hp_wNqx\Ij["JLG';AZuP{, e1[hamw$]Bci[R" ԝ*meⴝ?a{VWnVEpb2kng]A{a,]8#O$HG8<Ni)i1LSI`6v(GKbqT'fV*ŘʵkcڨMgۋ"3٭H' Lv9Z.{ghSzVrx*?*+[F_No/*=v֌ 0#\_ҎV}kXg\`JK퍥c#BELn=⤵UnqVG_+=Q FKBr \sf X&i\ܼ܌m锕q` Teʃ}8H.l嫍Fq\If\Y~ZϖӒ1[ơRygҴ֔Y`*ӝc3>VвtE/h=>_2+"F{p4c$5iV[mgB{inO%CU-o?s',am7VW2\jQMs+4hĦd{?8YcH(3gEw19ZM:d#4"ȘNħ Tm.aBCc[e^j tZ"&.k9.,\"Zw~qhw2!oǵq-.U9FA#QX*Rq.Hu.URD`A;\ilG1>J Gב"d-2(ׇ3m|GVR0~>%ٴNG)?ʮYxFkmj$*y t;X:֛.c(hSRY:qR4rWײ 垙' SbK)i1Nhچ+GZKr2Z/4_KM[Vi'ܬV6ܱ=j-ԣ Thت/l\5e)X0:OmoQ*#8<ڽ'HY'i)˙`dg_[)T%+UW\ ձ ( ߕk7&Κ[r2Zx{Kgī$w ?1?7Y)fd@yBmstjIgu{&m"{Ui }_'}-gR0G t}z4WوBS;} HjNE;bF}2"NYFV¸$ΔY9hۨ`R[$d#;ӺARiWpT\r*cgy3x Nx#܊ #ŷ>uY0nd0Tzgֽ׋4bL:_d\ zr,udUU *8#'&۽wZ0:=b}ȉ)ey]P7cRXf?.3 w2˱̣v?Bob[g%rAq &=oz#j"6Z)'զxq ׶{s7 ԅ\Vj2O e'Z#PQxJpw,3|e{V bIp!r9k>$]9g춬BpOWgq%ʧ2R<٤ӂ=#9ҭE8mđ+h˨uՌ32[|W޺O w2^[?6VSê0SiL5\\Iqg؆t~a9<:~s[Co|p ~=0YŽĜWX#zn'}(Rv6֝ry+>V;E_^3Y p#>1]駱MnKMiip'Oh/ގ>j+X] k8_>hw:ᡛK B \krZ2²tW_߇B2 \˟؟ڼA^'mϖ0gBc^jwYm'XGh͇B;VS.huaB1ҬYDafa\^_B۱OI >eQZF]ݖװFl٣"=/]dk< ʌ p15?<=mlm`-V^}"R[_P:HO~)A'+ݘk+i)[%nd>S{W!XrF+8QHwi7qұmai{ )|X}:(X)"2H 59m~6c/t  ~W<>)X4g<1M#qM0:p]!E}+lNKWCFSfMW|:мYLdh]DB+ֵm # I4095fMw~ԭNg"?t9zW7ZK`3EAF]=G׫jFW'7Ogb@, ~?ΡM6cioqW<9\-֭(|z8קhƟ#.(O?6\ y3*>#R[DZI}\lkY'!An85z)uaI \SzTi2imYHl$Wl3>46Շ8G-xLXAiXqWFSROghw6qwD1;3ss[KuNe8=ƹBm^'wEg4FVY*^Lөu1Z&$''ueLjEIdu)+)#!}|TF*N)S$k=:x-T09Myӕ05!`v&r%h!y0mΌTI0)#!x2x1e޽T/#Eu'\F$vjNzzXcIR2L{^/-x6kҾBne몌Tkc!KA5I üۼM4v2}(78'g{c(s=NvDO(LN:&+nn0uBOμu'"nq (IZ7II]&EjJВ''<ջU aQSKd6M?J{֐]x'8H\ڦˠ$`b??Z(hn!nQ( akk׷6j 0+E>9Pu؁BOZ(jl ={S[y*g<ĖLeY!eiA⡎VeRrvEB8¸_ʕE#y}4< lۭ0áō̐Ap{Ԋt${T'^,l(f%֊M(1"=Nn@$枃L֠g 8i1F :R$mUǨv|齩g,r95glƁ zdp{r3 ֓h$tzQsM(XwZ>@ +H8\@E(#ӑH榩sL)A .L wd}P~ThdV _^ԊI 㚛V :8&xrދ>2 $NM9yR^"h@2@܂qRJwl v>ݥaYcA3T ;!(#NF{OZMߝFO SOI) Px“i)vCE(iIJɷ&8Aϥ]xDE ',J5pi=L؞C{XC2 ǩq(bӦk8e]9\WQ\[_Cmhg\=] fRim;)x?Zm5m=O\)rkMDW!%Pre>\.O6Nn<J  6h@@"^@={T=1NF ӵ;n.z\Hpsp8vzzTN>Py<@\ wjLuThe feeling gained from such a victory is indescribable. This was what we had been hoping, praying and working for all year. We worked so hard to get there, putting in countless hours in the weight room and dedicating ourselves to practice. This is the biggest accomplishment of our lives thus far. We will never forget what happened out on that field. It is a memory that will last a lifetime. FDA has been studying creatine since it exploded onto the sports scene in 1992. Dr. Mike Stone from Appalachian State University, a leader in the field of Muscle Physiology, has been studying athletes who have been taking creatine for as long as six years. To date, there are no reports of kidney, heart or liver problems.<br>Since there is no documented evidence that creatine is a health hazard, the benefits of accelerated muscle development using creatine, far outweigh at least one alternative - using anabolic steroids. For those concerned about sending the wrong message to young adults, consider this; it is a